-
3
-
-
0033916382
-
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
-
10925089 Epub 2000/08/05
-
Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology. 2000; 56(2):255-60. Epub 2000/08/05. PMID: 10925089.
-
(2000)
Urology.
, vol.56
, Issue.2
, pp. 255-260
-
-
Catalona, W.J.1
Southwick, P.C.2
Slawin, K.M.3
Partin, A.W.4
Brawer, M.K.5
Flanigan, R.C.6
-
4
-
-
77949363162
-
American Cancer Society guideline for the early detection of prostate cancer: Update 2010
-
20200110 Epub 2010/03/05
-
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA: a cancer journal for clinicians. 2010; 60(2):70-98. Epub 2010/03/05. doi: 10.3322/caac.20066 PMID: 20200110.
-
(2010)
CA: A Cancer Journal for Clinicians.
, vol.60
, Issue.2
, pp. 70-98
-
-
Wolf, A.M.1
Wender, R.C.2
Etzioni, R.B.3
Thompson, I.M.4
D'Amico, A.V.5
Volk, R.J.6
-
5
-
-
0030913316
-
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
-
9145717 Epub 1997/05/14
-
Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA: the journal of the American Medical Association. 1997; 277(18):1452-5. Epub 1997/05/14. PMID: 9145717.
-
(1997)
JAMA: The Journal of the American Medical Association.
, vol.277
, Issue.18
, pp. 1452-1455
-
-
Catalona, W.J.1
Smith, D.S.2
Ornstein, D.K.3
-
6
-
-
2442715038
-
Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter
-
15163773
-
Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. The New England journal of medicine. 2004; 350(22):2239-46. PMID: 15163773
-
(2004)
The New England Journal of Medicine.
, vol.350
, Issue.22
, pp. 2239-2246
-
-
Thompson, I.M.1
Pauler, D.K.2
Goodman, P.J.3
Tangen, C.M.4
Lucia, M.S.5
Parnes, H.L.6
-
7
-
-
0028256194
-
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
-
7512659 Epub 1994/05/01
-
Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. The Journal of urology. 1994; 151(5):1283-90. Epub 1994/05/01. PMID: 7512659.
-
(1994)
The Journal of Urology.
, vol.151
, Issue.5
, pp. 1283-1290
-
-
Catalona, W.J.1
Richie, J.P.2
Ahmann, F.R.3
Hudson, M.A.4
Scardino, P.T.5
Flanigan, R.C.6
-
8
-
-
0033926998
-
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection
-
10893592 Epub 2000/07/14
-
Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. The Journal of urology. 2000; 164(2):388-92. Epub 2000/07/14. PMID: 10893592.
-
(2000)
The Journal of Urology.
, vol.164
, Issue.2
, pp. 388-392
-
-
Naughton, C.K.1
Miller, D.C.2
Mager, D.E.3
Ornstein, D.K.4
Catalona, W.J.5
-
9
-
-
77950498003
-
Effect of dutasteride on the risk of prostate cancer
-
20357281 Epub 2010/04/02
-
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. The New England journal of medicine. 2010; 362(13):1192-202. Epub 2010/04/02. doi: 10.1056/NEJMoa0908127 PMID: 20357281.
-
(2010)
The New England Journal of Medicine.
, vol.362
, Issue.13
, pp. 1192-1202
-
-
Andriole, G.L.1
Bostwick, D.G.2
Brawley, O.W.3
Gomella, L.G.4
Marberger, M.5
Montorsi, F.6
-
10
-
-
77955860271
-
Dutasteride and prostate cancer
-
20842789 author reply 4-5. Epub 2010/09/17
-
Schroder FH, Roobol MJ. Dutasteride and prostate cancer. The New England journal of medicine. 2010; 363(8):793-4; author reply 4-5. Epub 2010/09/17. PMID: 20842789.
-
(2010)
The New England Journal of Medicine.
, vol.363
, Issue.8
, pp. 793-794
-
-
Schroder, F.H.1
Roobol, M.J.2
-
11
-
-
33646942410
-
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
-
16627561 Epub 2006/04/22
-
Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clinical chemistry. 2006; 52 (6):1089-95. Epub 2006/04/22. doi: 10.1373/clinchem.2005.063289 PMID: 16627561.
-
(2006)
Clinical Chemistry.
, vol.52
, Issue.6
, pp. 1089-1095
-
-
Groskopf, J.1
Aubin, S.M.2
Deras, I.L.3
Blase, A.4
Bodrug, S.5
Clark, C.6
-
12
-
-
44049098496
-
Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): A more specific and sensitive marker than conventional serum total PSA
-
18489403 Epub 2008/05/21
-
Herwig R, Mitteregger D, Djavan B, Kramer G, Margreiter M, Leers MP, et al. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA. European journal of clinical investigation. 2008; 38(6):430-7. Epub 2008/05/21. doi: 10.1111/j.1365-2362.2008.01953.x PMID: 18489403.
-
(2008)
European Journal of Clinical Investigation.
, vol.38
, Issue.6
, pp. 430-437
-
-
Herwig, R.1
Mitteregger, D.2
Djavan, B.3
Kramer, G.4
Margreiter, M.5
Leers, M.P.6
-
13
-
-
84876473108
-
Serum isoform [-2] proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: A multicentric European study
-
23375961
-
Lazzeri M, Haese A, de la Taille A, Palou RJ, McNicholas T, Lughezzani G, et al. Serum isoform [-2] proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study. European urology. 2013; 63(6):986-94. doi: 10.1016/j.eururo.2013.01.011 PMID: 23375961
-
(2013)
European Urology.
, vol.63
, Issue.6
, pp. 986-994
-
-
Lazzeri, M.1
Haese, A.2
De La Taille, A.3
Palou, R.J.4
McNicholas, T.5
Lughezzani, G.6
-
14
-
-
34147136783
-
EPCA-2: A highly specific serum marker for prostate cancer
-
17445657 Epub 2007/04/21
-
Leman ES, Cannon GW, Trock BJ, Sokoll LJ, Chan DW, Mangold L, et al. EPCA-2: a highly specific serum marker for prostate cancer. Urology. 2007; 69(4):714-20. Epub 2007/04/21. doi: 10.1016/j. urology.2007.01.097 PMID: 17445657.
-
(2007)
Urology.
, vol.69
, Issue.4
, pp. 714-720
-
-
Leman, E.S.1
Cannon, G.W.2
Trock, B.J.3
Sokoll, L.J.4
Chan, D.W.5
Mangold, L.6
-
15
-
-
57249095672
-
Annexin A3 in urine: A highly specific noninvasive marker for prostate cancer early detection
-
19012935 Epub 2008/11/18
-
Schostak M, Schwall GP, Poznanovic S, Groebe K, Muller M, Messinger D, et al. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection. The Journal of urology. 2009; 181(1):343-53. Epub 2008/11/18. doi: 10.1016/j.juro.2008.08.119 PMID: 19012935.
-
(2009)
The Journal of Urology.
, vol.181
, Issue.1
, pp. 343-353
-
-
Schostak, M.1
Schwall, G.P.2
Poznanovic, S.3
Groebe, K.4
Muller, M.5
Messinger, D.6
-
16
-
-
34548863661
-
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
-
17785564 Epub 2007
-
Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clinical Cancer Research. 2007; 13:5103-8. Epub 2007. PMID: 17785564
-
(2007)
Clinical Cancer Research.
, vol.13
, pp. 5103-5108
-
-
Hessels, D.1
Smit, F.P.2
Verhaegh, G.W.3
Witjes, J.A.4
Cornel, E.B.5
Schalken, J.A.6
-
17
-
-
79961222799
-
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
-
21813756 Epub 2011/08/05. PubMed Central PMCID: PMC3245713
-
Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, et al. Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Science translational medicine. 2011; 3(94):94ra72. Epub 2011/08/05. doi: 10.1126/scitranslmed.3001970 PMID: 21813756; PubMed Central PMCID: PMC3245713.
-
(2011)
Science Translational Medicine.
, vol.3
, Issue.94
, pp. 94ra72
-
-
Tomlins, S.A.1
Aubin, S.M.2
Siddiqui, J.3
Lonigro, R.J.4
Sefton-Miller, L.5
Miick, S.6
-
18
-
-
17744400811
-
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL
-
9730444 Epub 1998/09/08
-
Kwiatkowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, et al. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL. Urology. 1998; 52 (3):360-5. Epub 1998/09/08. PMID: 9730444.
-
(1998)
Urology.
, vol.52
, Issue.3
, pp. 360-365
-
-
Kwiatkowski, M.K.1
Recker, F.2
Piironen, T.3
Pettersson, K.4
Otto, T.5
Wernli, M.6
-
19
-
-
79952265301
-
Engrailed-2 (EN2): A tumor specific urinary biomarker for the early diagnosis of prostate cancer
-
21364037 Epub 2011/03/03
-
Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, et al. Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011; 17(5):1090-8. Epub 2011/03/03. doi: 10.1158/1078-0432.CCR-10-2410 PMID: 21364037.
-
(2011)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research.
, vol.17
, Issue.5
, pp. 1090-1098
-
-
Morgan, R.1
Boxall, A.2
Bhatt, A.3
Bailey, M.4
Hindley, R.5
Langley, S.6
-
20
-
-
84889565733
-
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men
-
ISI:000320754200007
-
Killick E, Morgan R, Launchbury F, Bancroft E, Page E, Castro E, et al. Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Sci Rep-Uk. 2013; 3. ISI:000320754200007.
-
(2013)
Sci Rep-UK.
, vol.3
-
-
Killick, E.1
Morgan, R.2
Launchbury, F.3
Bancroft, E.4
Page, E.5
Castro, E.6
-
21
-
-
35748947727
-
Challenges of cancer biomarker profiling
-
17919807 Epub 2007/10/09
-
Bensalah K, Montorsi F, Shariat SF. Challenges of cancer biomarker profiling. European urology. 2007; 52(6):1601-9. Epub 2007/10/09. doi: 10.1016/j.eururo.2007.09.036 PMID: 17919807.
-
(2007)
European Urology.
, vol.52
, Issue.6
, pp. 1601-1609
-
-
Bensalah, K.1
Montorsi, F.2
Shariat, S.F.3
-
22
-
-
34047099256
-
Role of nomograms for prostate cancer in 2007
-
17333203 Epub 2007/03/03
-
Chun FK, Karakiewicz PI, Huland H, Graefen M. Role of nomograms for prostate cancer in 2007. World journal of urology. 2007; 25(2):131-42. Epub 2007/03/03. doi: 10.1007/s00345-007-0146-y PMID: 17333203.
-
(2007)
World Journal of Urology.
, vol.25
, Issue.2
, pp. 131-142
-
-
Chun, F.K.1
Karakiewicz, P.I.2
Huland, H.3
Graefen, M.4
-
23
-
-
60149091657
-
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
-
19212411 Epub 2009/02/13. PubMed Central PMCID: PMC2724746
-
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457(7231):910-4. Epub 2009/02/13. doi: 10.1038/nature07762 PMID: 19212411; PubMed Central PMCID: PMC2724746.
-
(2009)
Nature.
, vol.457
, Issue.7231
, pp. 910-914
-
-
Sreekumar, A.1
Poisson, L.M.2
Rajendiran, T.M.3
Khan, A.P.4
Cao, Q.5
Yu, J.6
-
24
-
-
77955517340
-
Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours
-
20117878 ISI:000278414100003
-
Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. European urology. 2010; 58(1):12-8. doi: 10.1016/j.eururo.2010.01.035. ISI:000278414100003. PMID: 20117878
-
(2010)
European Urology.
, vol.58
, Issue.1
, pp. 12-18
-
-
Jentzmik, F.1
Stephan, C.2
Miller, K.3
Schrader, M.4
Erbersdobler, A.5
Kristiansen, G.6
-
25
-
-
77951849434
-
Serum sarcosine is not a marker for prostate cancer
-
Epub 2010
-
Struys EA, Heijboer AC, Moorselaar JV, Jakobs C, Blankenstein MA. Serum sarcosine is not a marker for prostate cancer. Annals of Clinical Biochemistry. 2010; 47(3):282. Epub 2010. doi: 10.1258/acb. 2010.009270
-
(2010)
Annals of Clinical Biochemistry.
, vol.47
, Issue.3
, pp. 282
-
-
Struys, E.A.1
Heijboer, A.C.2
Moorselaar, J.V.3
Jakobs, C.4
Blankenstein, M.A.5
-
26
-
-
79960561808
-
GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization
-
21626193 Epub 2011/06/01
-
Wu H, Liu T, Ma C, Xue R, Deng C, Zeng H, et al. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Analytical and bioanalytical chemistry. 2011; 401(2):635-46. Epub 2011/06/01. doi: 10.1007/s00216-011-5098-9 PMID: 21626193.
-
(2011)
Analytical and Bioanalytical Chemistry.
, vol.401
, Issue.2
, pp. 635-646
-
-
Wu, H.1
Liu, T.2
Ma, C.3
Xue, R.4
Deng, C.5
Zeng, H.6
-
27
-
-
4644223628
-
Evidence for canine olfactory detection of melanoma
-
ISI:000224591700009
-
Pickel D, Manucy GP, Walker DB, Hall SB, Walker JC. Evidence for canine olfactory detection of melanoma. Appl Anim Behav Sci. 2004; 89(1-2):107-16. doi: 10.1016/j.applanim.2004.04.008. ISI:000224591700009.
-
(2004)
Appl Anim Behav Sci.
, vol.89
, Issue.1-2
, pp. 107-116
-
-
Pickel, D.1
Manucy, G.P.2
Walker, D.B.3
Hall, S.B.4
Walker, J.C.5
-
28
-
-
4744340118
-
Olfactory detection of human bladder cancer by dogs: Proof of principle study
-
15388612 Epub 2004/09/25. PubMed Central PMCID: PMC518893
-
Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. Bmj. 2004; 329(7468):712. Epub 2004/09/25. doi: 10.1136/bmj.329.7468.712 PMID: 15388612; PubMed Central PMCID: PMC518893.
-
(2004)
Bmj
, vol.329
, Issue.7468
, pp. 712
-
-
Willis, C.M.1
Church, S.M.2
Guest, C.M.3
Cook, W.A.4
McCarthy, N.5
Bransbury, A.J.6
-
29
-
-
32944463513
-
Diagnostic accuracy of canine scent detection in early-and late-stage lung and breast cancers
-
16484712 ISI:000237583100004
-
McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early-and late-stage lung and breast cancers. Integr Cancer Ther. 2006; 5(1):30-9. doi: 10.1177/1534735405285096. ISI:000237583100004. PMID: 16484712
-
(2006)
Integr Cancer Ther.
, vol.5
, Issue.1
, pp. 30-39
-
-
McCulloch, M.1
Jezierski, T.2
Broffman, M.3
Hubbard, A.4
Turner, K.5
Janecki, T.6
-
30
-
-
44949093749
-
Human ovarian carcinomas detected by specific odor
-
18505901 ISI:000256934000004
-
Horvath G, Jarverud GA, Jarverud S, Horvath I. Human ovarian carcinomas detected by specific odor. Integr Cancer Ther. 2008; 7(2):76-80. doi: 10.1177/1534735408319058. ISI:000256934000004. PMID: 18505901
-
(2008)
Integr Cancer Ther.
, vol.7
, Issue.2
, pp. 76-80
-
-
Horvath, G.1
Jarverud, G.A.2
Jarverud, S.3
Horvath, I.4
-
31
-
-
78650706114
-
Olfactory detection of prostate cancer by dogs sniffing urine: A step forward in early diagnosis
-
20970246 Epub 2010/10/26
-
Cornu JN, Cancel-Tassin G, Ondet V, Girardet C, Cussenot O. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. European urology. 2011; 59(2):197-201. Epub 2010/10/26. doi: 10.1016/j.eururo.2010.10.006 PMID: 20970246.
-
(2011)
European Urology.
, vol.59
, Issue.2
, pp. 197-201
-
-
Cornu, J.N.1
Cancel-Tassin, G.2
Ondet, V.3
Girardet, C.4
Cussenot, O.5
-
32
-
-
84896131879
-
Key considerations for the experimental training and evaluation of cancer odour detection dogs: Lessons learnt from a doubleblind, controlled trial of prostate cancer detection
-
24575737 Epub 2014/03/01. PubMed Central PMCID: PMC3945616
-
Elliker KR, Sommerville BA, Broom DM, Neal DE, Armstrong S, Williams HC. Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a doubleblind, controlled trial of prostate cancer detection. BMC urology. 2014; 14:22. Epub 2014/03/01. doi: 10.1186/1471-2490-14-22 PMID: 24575737; PubMed Central PMCID: PMC3945616.
-
(2014)
BMC Urology.
, vol.14
, pp. 22
-
-
Elliker, K.R.1
Sommerville, B.A.2
Broom, D.M.3
Neal, D.E.4
Armstrong, S.5
Williams, H.C.6
-
33
-
-
84957577716
-
PD19-01 Prostate cancer urine detection through highly-trained dogs' olfactory system: A real clinical opportunity
-
April 2014; Orlando, Florida, USA: The Journal of Urology
-
Taverna G, Tidu L, Grizzi F, Giusti G, Seveso M, Benetti A, et al. PD19-01 Prostate cancer urine detection through highly-trained dogs' olfactory system: a real clinical opportunity. American Urological Association 109th Annual Meeting; April 2014; Orlando, Florida, USA: The Journal of Urology; 2014. p. e546.
-
(2014)
American Urological Association 109th Annual Meeting
, pp. e546
-
-
Taverna, G.1
Tidu, L.2
Grizzi, F.3
Giusti, G.4
Seveso, M.5
Benetti, A.6
-
34
-
-
84902548813
-
Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study
-
24582536 Epub 2014/03/04
-
Roine A, Veskimae E, Tuokko A, Kumpulainen P, Koskimaki J, Keinanen TA, et al. Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study. The Journal of urology. 2014. Epub 2014/03/04. doi: 10.1016/j.juro.2014.01.113 PMID: 24582536.
-
(2014)
The Journal of Urology.
-
-
Roine, A.1
Veskimae, E.2
Tuokko, A.3
Kumpulainen, P.4
Koskimaki, J.5
Keinanen, T.A.6
-
35
-
-
84901242628
-
Prostate cancer diagnosis through electronic nose in the urine headspace setting: A pilot study
-
ISI:000336354600016
-
Asimakopoulos AD, Del Fabbro D, Miano R, Santonico M, Capuano R, Pennazza G, et al. Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study. Prostate Cancer P D. 2014; 17(2):206-11. doi: 10.1038/Pcan.2014.11. ISI:000336354600016.
-
(2014)
Prostate Cancer P D.
, vol.17
, Issue.2
, pp. 206-211
-
-
Asimakopoulos, A.D.1
Del Fabbro, D.2
Miano, R.3
Santonico, M.4
Capuano, R.5
Pennazza, G.6
-
36
-
-
65749091066
-
A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry
-
WOS:000207696000024
-
Smith S, Burden H, Persad R, Whittington K, Costello BD, Ratcliffe NM, et al. A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry. J Breath Res. 2008; 2(3). doi: 10.1088/1752-7155/2/3/037022. WOS:000207696000024.
-
(2008)
J Breath Res.
, vol.2
, Issue.3
-
-
Smith, S.1
Burden, H.2
Persad, R.3
Whittington, K.4
Costello, B.D.5
Ratcliffe, N.M.6
-
37
-
-
84921860640
-
Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs)
-
25270935
-
Zhang S, Raftery D. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs). Methods Mol Biol. 2014; 1198:265-72. doi: 10.1007/978-1-4939-1258-2-17 PMID: 25270935.
-
(2014)
Methods Mol Biol.
, vol.1198
, pp. 265-272
-
-
Zhang, S.1
Raftery, D.2
-
38
-
-
84856355144
-
Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers - A powerful strategy for breast cancer diagnosis
-
22284503
-
Silva CL, Passos M, Camara JS. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers - a powerful strategy for breast cancer diagnosis. Talanta. 2012; 89:360-8. doi: 10.1016/j.talanta.2011.12.041 PMID: 22284503.
-
(2012)
Talanta.
, vol.89
, pp. 360-368
-
-
Silva, C.L.1
Passos, M.2
Camara, J.S.3
-
39
-
-
0035810329
-
Headspace solid-phase microextraction profiling of volatile compounds in urine: Application to metabolic investigations
-
11334339
-
Mills GA, Walker V. Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations. J Chromatogr B Biomed Sci Appl. 2001; 753(2):259-68. PMID: 11334339.
-
(2001)
J Chromatogr B Biomed Sci Appl.
, vol.753
, Issue.2
, pp. 259-268
-
-
Mills, G.A.1
Walker, V.2
-
40
-
-
79961174954
-
Metab: An R package for high-throughput analysis of metabolomics data generated by GC-MS
-
21697128 ISI:000293620800026
-
Aggio R, Villas-Boas SG, Ruggiero K. Metab: an R package for high-throughput analysis of metabolomics data generated by GC-MS. Bioinformatics. 2011; 27(16):2316-8. doi: 10.1093/bioinformatics/btr379. ISI:000293620800026. PMID: 21697128
-
(2011)
Bioinformatics.
, vol.27
, Issue.16
, pp. 2316-2318
-
-
Aggio, R.1
Villas-Boas, S.G.2
Ruggiero, K.3
-
41
-
-
77958158373
-
Feature selection with the boruta package
-
ISI:000282057200001
-
Kursa MB, Rudnicki WR. Feature Selection with the Boruta Package. J Stat Softw. 2010; 36(11):1-13. ISI:000282057200001.
-
(2010)
J Stat Softw.
, vol.36
, Issue.11
, pp. 1-13
-
-
Kursa, M.B.1
Rudnicki, W.R.2
-
42
-
-
56249113343
-
Building Predictive Models in R Using the caret Package
-
ISI:000260799600001
-
Kuhn M. Building Predictive Models in R Using the caret Package. J Stat Softw. 2008; 28(5):1-26. ISI:000260799600001.
-
(2008)
J Stat Softw.
, vol.28
, Issue.5
, pp. 1-26
-
-
Kuhn, M.1
-
43
-
-
0004200962
-
-
1st ed. London, UK: SAGE Publications Ltd
-
Klecka WR. Discriminant analysis. 1st ed. London, UK: SAGE Publications Ltd; 1980. 71 p.
-
(1980)
Discriminant Analysis
-
-
Klecka, W.R.1
-
44
-
-
33750724182
-
Reducing over-optimism in variable selection by crossmodel validation
-
ISI:000242768200011
-
Anderssen E, Dyrstad K, Westad F, Martens H. Reducing over-optimism in variable selection by crossmodel validation. Chemometr Intell Lab. 2006; 84(1-2):69-74. doi: 10.1016/j.chemolab.2006.04.021. ISI:000242768200011.
-
(2006)
Chemometr Intell Lab.
, vol.84
, Issue.1-2
, pp. 69-74
-
-
Anderssen, E.1
Dyrstad, K.2
Westad, F.3
Martens, H.4
-
45
-
-
64249132460
-
Repeated double cross validation
-
ISI:000265303100008
-
Filzmoser P, Liebmann B, Varmuza K. Repeated double cross validation. J Chemometr. 2009; 23(3-4):160-71. doi: 10.1002/Cem.1225. ISI:000265303100008.
-
(2009)
J Chemometr.
, vol.23
, Issue.3-4
, pp. 160-171
-
-
Filzmoser, P.1
Liebmann, B.2
Varmuza, K.3
-
46
-
-
59349116912
-
Analysis of cancer data: A data mining approach
-
ISI:000262951800010
-
Delen D. Analysis of cancer data: a data mining approach. Expert Syst. 2009; 26(1):100-12. doi: 10.1111/j.1468-0394.2008.00480.x. ISI:000262951800010.
-
(2009)
Expert Syst.
, vol.26
, Issue.1
, pp. 100-112
-
-
Delen, D.1
-
47
-
-
77954676863
-
Permutation tests for studying classifier performance
-
ISI:000282522400003
-
Ojala M, Garriga GC. Permutation Tests for Studying Classifier Performance. J Mach Learn Res. 2010; 11:1833-63. ISI:000282522400003.
-
(2010)
J Mach Learn Res.
, vol.11
, pp. 1833-1863
-
-
Ojala, M.1
Garriga, G.C.2
-
48
-
-
85008006367
-
Application of similarity coefficients to predict disease using volatile organic compounds
-
ISI:000272731700004
-
Smith S, White P, Redding J, Ratcliffe NM, Probert CSJ. Application of Similarity Coefficients to Predict Disease Using Volatile Organic Compounds. Ieee Sens J. 2010; 10(1):92-6. doi: 10.1109/Jsen.2009. 2035771. ISI:000272731700004.
-
(2010)
Ieee Sens J.
, vol.10
, Issue.1
, pp. 92-96
-
-
Smith, S.1
White, P.2
Redding, J.3
Ratcliffe, N.M.4
Probert, C.S.J.5
-
49
-
-
77955515058
-
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors
-
20648015 ISI:000280732100016
-
Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. British journal of cancer. 2010; 103(4):542-51. doi: 10.1038/sj.bjc.6605810. ISI:000280732100016. PMID: 20648015
-
(2010)
British Journal of Cancer.
, vol.103
, Issue.4
, pp. 542-551
-
-
Peng, G.1
Hakim, M.2
Broza, Y.Y.3
Billan, S.4
Abdah-Bortnyak, R.5
Kuten, A.6
-
50
-
-
84859154379
-
Beyond PSA: The next generation of prostate cancer biomarkers
-
22461644 PubMed Central PMCID: PMC3799996. Epub 2012/03/31
-
Prensner JR, Rubin MA, Wei JT, Chinnaiyan AM. Beyond PSA: the next generation of prostate cancer biomarkers. Science translational medicine. 2012; 4(127):127rv3. Epub 2012/03/31. doi: 10.1126/scitranslmed.3003180 PMID: 22461644; PubMed Central PMCID: PMC3799996.
-
(2012)
Science Translational Medicine.
, vol.4
, Issue.127
, pp. 127rv3
-
-
Prensner, J.R.1
Rubin, M.A.2
Wei, J.T.3
Chinnaiyan, A.M.4
-
51
-
-
77957339489
-
Multivariate meta-analysis of proteomics data from human prostate and colon tumours
-
20849579 PubMed Central PMCID: PMC2949896. Epub 2010/09/21
-
Rosenberg LH, Franzen B, Auer G, Lehtio J, Forshed J. Multivariate meta-analysis of proteomics data from human prostate and colon tumours. BMC bioinformatics. 2010; 11:468. Epub 2010/09/21. doi: 10.1186/1471-2105-11-468 PMID: 20849579; PubMed Central PMCID: PMC2949896.
-
(2010)
BMC Bioinformatics.
, vol.11
, pp. 468
-
-
Rosenberg, L.H.1
Franzen, B.2
Auer, G.3
Lehtio, J.4
Forshed, J.5
-
52
-
-
84861477023
-
The versatile use of exhaled volatile organic compounds in human health and disease
-
ISI:000304411600014
-
Boots AW, van Berkel JJBN, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ. The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res. 2012; 6(2). doi: 10.1088/1752-7155/6/2/027108. ISI:000304411600014.
-
(2012)
J Breath Res.
, vol.6
, Issue.2
-
-
Boots, A.W.1
Van Berkel, J.J.B.N.2
Dallinga, J.W.3
Smolinska, A.4
Wouters, E.F.5
Van Schooten, F.J.6
-
53
-
-
84856047358
-
Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry
-
Silva CL, Passos M, Camara JS. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. British journal of cancer. 2011; 105(12):1894-904.
-
(2011)
British Journal of Cancer.
, vol.105
, Issue.12
, pp. 1894-1904
-
-
Silva, C.L.1
Passos, M.2
Camara, J.S.3
-
54
-
-
60849086758
-
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro
-
19025629 PubMed Central PMCID: PMC2639533 Epub 2008/11/26
-
Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, et al. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer cell international. 2008; 8:17. Epub 2008/11/26. doi: 10.1186/1475-2867-8-17 PMID: 19025629; PubMed Central PMCID: PMC2639533.
-
(2008)
Cancer Cell International.
, vol.8
, pp. 17
-
-
Filipiak, W.1
Sponring, A.2
Mikoviny, T.3
Ager, C.4
Schubert, J.5
Miekisch, W.6
-
55
-
-
77956535473
-
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: Exploring the value of PCA3 for a first-line diagnostic test
-
20637539 Epub 2010/07/20
-
Roobol MJ, Schroder FH, van Leeuwen P, Wolters T, van den Bergh RC, van Leenders GJ, et al. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. European urology. 2010; 58(4):475-81. Epub 2010/07/20. doi: 10.1016/j.eururo.2010.06.039 PMID: 20637539.
-
(2010)
European Urology.
, vol.58
, Issue.4
, pp. 475-481
-
-
Roobol, M.J.1
Schroder, F.H.2
Van Leeuwen, P.3
Wolters, T.4
Van Den Bergh, R.C.5
Van Leenders, G.J.6
-
56
-
-
38849169937
-
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
-
18245462 PubMed Central PMCID: PMC2998181. Epub 2008/02/05
-
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer research. 2008; 68(3):645-9. Epub 2008/02/05. doi: 10.1158/0008-5472.CAN-07-3224 PMID: 18245462; PubMed Central PMCID: PMC2998181.
-
(2008)
Cancer Research.
, vol.68
, Issue.3
, pp. 645-649
-
-
Laxman, B.1
Morris, D.S.2
Yu, J.3
Siddiqui, J.4
Cao, J.5
Mehra, R.6
-
57
-
-
79953777963
-
A Multicenter Study of [-2]P with Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
-
ISI:000289279600032
-
Catalona WJ, Partin AW, Sanda MG, Wei JT, Klee GG, Bangma CH, et al. A Multicenter Study of [-2]P With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range. J Urology. 2011; 185(5):1650-5. doi: 10.1016/j.juro. 2010.12.032. ISI:000289279600032.
-
(2011)
J Urology.
, vol.185
, Issue.5
, pp. 1650-1655
-
-
Catalona, W.J.1
Partin, A.W.2
Sanda, M.G.3
Wei, J.T.4
Klee, G.G.5
Bangma, C.H.6
-
58
-
-
84909963352
-
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy
-
24361258 Epub 2013/12/24
-
Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, et al. Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy. European urology. 2013; 66(5). Epub 2013/12/24. doi: 10.1016/j.eururo.2013.12.005 PMID: 24361258.
-
(2013)
European Urology.
, vol.66
, Issue.5
-
-
Lughezzani, G.1
Lazzeri, M.2
Haese, A.3
McNicholas, T.4
De La Taille, A.5
Buffi, N.M.6
|